000 | 01677 a2200481 4500 | ||
---|---|---|---|
005 | 20250516194341.0 | ||
264 | 0 | _c20150811 | |
008 | 201508s 0 0 eng d | ||
022 | _a1533-1601 | ||
024 | 7 |
_a10.1177/0192623313520350 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aInomata, Akira | |
245 | 0 | 0 |
_aBrunner's gland lesions in rats induced by a vascular endothelial growth factor receptor inhibitor. _h[electronic resource] |
260 |
_bToxicologic pathology _cDec 2014 |
||
300 |
_a1267-74 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBrunner Glands _xcytology |
650 | 0 | 4 |
_aDuodenal Diseases _xchemically induced |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHyperplasia _xchemically induced |
650 | 0 | 4 |
_aInflammation _xchemically induced |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPhenylurea Compounds _xadministration & dosage |
650 | 0 | 4 |
_aQuinolines _xadministration & dosage |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptor Protein-Tyrosine Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
700 | 1 | _aNakano-Ito, Kyoko | |
700 | 1 | _aFujikawa, Yasuhiro | |
700 | 1 | _aSonoda, Jiro | |
700 | 1 | _aHayakawa, Kazuhiro | |
700 | 1 | _aOhta, Etsuko | |
700 | 1 | _aTaketa, Yoshikazu | |
700 | 1 | _aVan Gessel, Yvonne | |
700 | 1 | _aAkare, Sandeep | |
700 | 1 | _aHutto, David | |
700 | 1 | _aHosokawa, Satoru | |
700 | 1 | _aTsukidate, Kazuo | |
773 | 0 |
_tToxicologic pathology _gvol. 42 _gno. 8 _gp. 1267-74 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/0192623313520350 _zAvailable from publisher's website |
999 |
_c23519373 _d23519373 |